In this study we evaluated the effect of
calpain inhibitor I on splanchnic artery occlusion (SAO)
shock-mediated injury. SAO
shock was induced in rats by clamping both the superior mesenteric artery and the celiac trunk for 45 min. After 1 h of reperfusion, SAO-shocked rats developed a significant fall in mean arterial blood pressure. Western blot analysis of ileum revealed a marked decrease in of
IkappaB-alpha expression, and immunohistochemical examination of necrotic ileum demonstrated a marked increase in the immunoreactivity to
P-selectin, intracellular adhesion molecule (ICAM-1),
nitrotyrosine formation, and nuclear
enzyme poly[
adenosine diphosphate (
ADP)-ribose] synthase (PARS) activation. An increase in
myeloperoxidase activity (143 +/- 22 4.5 U/100 mg wet tissue vs. 4.5 +/- 2.5 U/100 mg wet tissue of
sham-operated rats) and in
malondialdehyde levels (13.12 +/- 1.2 micromol/100 mg wet tissue vs. 3.9 +/- 1.1 micromol/100 mg wet tissue of
sham-operated rats) was also observed in rats subjected to
ischemia-reperfusion injury.
Calpain inhibitor I, given intraperitoneally 30 min before
ischemia at a dose of 15 mg/kg, significantly improved mean arterial blood pressure, markedly reduced
IkappaB-alpha degradation and the intensity of
P-selectin and
ICAM-1 in the reperfused ileum.
Calpain inhibitor I also significantly prevented neutrophil infiltration (32.95 +/- 9.82 U/100 mg wet tissue), reduced
malondialdehyde levels (6.76 +/- 0.98 micromol/100 mg wet tissue) and markedly improved the histological status of the reperfused tissue. In conclusion, this study demonstrates that
calpain inhibitor I exerts multiple protective effects in splanchnic artery occlusion-reperfusion
shock and suggests that
calpain inhibitor I may be a candidate for consideration as a therapeutic intervention for
ischemia-reperfusion injury.